InvestorsHub Logo

Biobillionair

08/10/16 8:03 PM

#88294 RE: bblack #88293

"Low likelyhood of stop"... Duh!

jfmcrr

08/10/16 8:05 PM

#88296 RE: bblack #88293

More data on Baker Bros....

One of their holdings, ACAD, just did a $200 million secondary. BB bought enough to roughly maintain their % stake in ACAD. I can't imagine that BB did not have the funds to pursue AMRN's deal, but they may not have felt compelled to participate for a myriad of reasons off percentages of the company, percentages of the portfolio, convertibles, whatever.

BioChica

08/10/16 8:13 PM

#88298 RE: bblack #88293

The notice of an offering with no share price or number of shares, before market closing did not make sense! Something odd about the way this was announced. Why bother, just do the PR after a deal is struck for number of shares and price.

This wording does not look like an overnight deal!

All of the shares in the proposed offering are to be sold by Amarin. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or the actual size or terms of the offering.

Mercator21

08/10/16 8:21 PM

#88301 RE: bblack #88293

I agree with JL on this
risk/reward is very favorable ahead of 1st interim and now with a 2nd interim look mid 2017, it is even more attractive, especially if you believe in EPA benefit

well, if you are an institution, you are getting the stock at 10-15% discount tonight and you have 2 shots on goal over the next 9 month before the final binary event. You assume that if 1st interim is not halted, you would probably find yourself in the same price range as you are today prior to 2nd interim. So your downside is limited for the next 9 month (i am not talking about day to day trading but over the course of 9 month). However, IF 1st interim is halted, you open in double digits. This is a very attractive risk/reward over the next 9 month.

btw, this raise has NOT changed the odds of 1st interim being halted or not whatsoever. The company simply needed to do one more raise to be able to get to the finish line. If you are familiar with their balance sheet, you are not surprised. No company waits and hopes. Your priority is to make sure you have enough cash to get you thru the worse case scenario (final R-IT), no matter how confident you are about the data. On that note, if 1st and 2nd is not halted, I would not be surprised to see another raise prior to final data. Basic survival 101.